Published Research

Parker DM, Stabler ME, Shi X, Zimmerman MS, MacKenzie TA. Geographic access to Specialty Care and Risk of Adverse Outcomes for Children with Congenital Heart Disease. Manuscript under review. 2023.

Parker DM, Stabler ME, Shi X, Zimmerman MS, MacKenzie TA. Specialty Care Visits and Likelihood of Mortality for Children with Congenital Heart Disease.  Manuscript under review. 2023.

Parker DM, Stabler ME, MacKenzie TA, Shi X, Zimmerman MS, Everett AD, Brown JR. Empirical Population-Based Estimates of the Prevalence of Children with Congenital Heart Disease. Manuscript under review. 2023.

Green MD, Parker DM, Everett AD, Vricella L, Jacobs ML, Jacobs JP, Brown JR. Cardiac biomarkers associated with hospital length of stay after pediatric congenital heart surgery. Ann Thorac Surg. 2021 Aug;112(2):632-637

Parker DM, Everett AD, Stabler ME, Jacobs ML, Jacobs JP, Vricella L, Thiessen-Philbrook H, Parikh CR, Manlhiot C, Brown JR. ST2 Predicts Risk of Unplanned Readmission Within 1 Year After Pediatric Congenital Heart Surgery. Ann Thorac Surg. 2020 Dec;110(6):2070-2075

Parsons MR, Parker DM, Parikh CR, Brown JR, Jacobs JP. Postoperative Acute Kidney Injury is Associated with a Biomarker of Acute Brain Injury after Pediatric Cardiac Surgery. Cardiol Young. 2020 Apr; 30(4):505-510

Everett AD, Alam SS, Owens SL, Parker DM, Likosky D, Thiessen-Philbrook H, Wyler von Ballmoos M, Lobdell K, MacKenzie TA, Jacobs JP, Parikh CR, DiScipio AW, Malenka DJ, Brown JR. The association between Cytokines and 365-day readmission or mortality in adult cardiac surgery. Journal of extracorporeal technology. Accepted August 27, 2019.

 Parker DM, Everett AD, Stabler ME, Vricella L, Jacobs ML, Jacobs JP, Parikh CR, Pasquali SK, Brown JR. Novel Biomarkers Improves Prediction of 365-day Readmission after Pediatric Congenital Heart Surgery. Ann Thorac Surg. 2019 Jul 16.

 Brown JR, Stabler ME, Parker DM, Vricella L, Pasquali S, Leyenaar JK, Bohm AR, MacKenzie T, Parikh CR, Jacobs ML, Jacobs JP, Everett AD. Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery. Cardiol Young. 2019 Jul 10:1-6.

Ramkumar N, Jacobs JP, Berman RB, Parker DM, MacKenzie TA, Likosky DS, DiScipio A, Malenka DJ, Brown JR. Cardiac Biomarkers Predict Long-Term Survival After Cardiac Surgery. Ann Thorac Surg. 2019 Jun 27.

Parker DM, Owens SL, Ramkumar N, Likosky D, DiScipio AW, Maleka DJ, MacKenzie TA, Brown JR. Galectin-3 as a Predictor of Long-term Survival after Isolated Coronary Artery Bypass Grafting Surgery. Ann Thorac Surg. 2019 Jul 20.

Parker DM, Everett AD, Stabler ME, Vricella L, Jacobs ML, Jacobs JP, Thiessen-Philbrook H, Parikh C, Brown JR. Biomarkers associated with 30-day readmission and mortality after pediatric congenital heart surgery. J Card Surg. 2019 May;34(5): 329-336.

Parker DM, Everett AD, Stabler ME, Vricella L, Jacobs ML, Jacobs JP, Thiessen-Philbrook H, Parikh CR, Brown JR. Preoperative NT-proBNP Predicts 30-day Readmission or Mortality After Pediatric Congenital Heart Surgery. World J Pediatr Congenit Heart Surg.

Parker DM, Brown JR. Biomarkers for the prediction of cardiac readmission. Biomark Med. 2019 Feb; 13(2): 55-58.

Jacobs JP, Alam SS, Owens SL, Parker DM, Rezaee M, Likosky DS, Shahian DM, Jacobs ML, Thiessen-Philbrook H, Wyler von Ballmoos M, Lobdell K, MacKenzie T, Everett AD, Parikh CR, Brown JR. The Association Between Novel Biomarkers and 1-Year Readmission or Mortality After Cardiac Surgery. Ann Thorac Surg. 2018 Oct;106(4):1122-1128

Lobdell K, Parker DM, Likosky DS, Rezaee M, Wyler von Ballmoos M, Alam S, Owens S, Thiessen-Philbrook H, MacKenzie T, Brown J. Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery. J Thorac Cardiovasc Surg. 2018 Sep;156(3):1114-1123

Brown JR, Jacobs JP, Alam SS, Thiessen-Philbrook H, Likosky DS, Lobdell K, Wyler Von Ballmoos M, Parker DM, Garg AZ, MacKenzie T, Jacobs ML, Parikh CR. Utility of biomarkers to improve prediction of readmission or mortality after cardiac surgery. Annals of Thoracic Surgery. 2018 Nov; 106(5): 1294-1301.

Polineni S, Parker DM, Alam S, Brown J. The predictive ability of novel cardiac biomarkers ST2, Galectin-3, and NT-proBNP prior to cardiac surgery. J Am Heart Assoc. 2018 Jul 7;7(14).  

Wyler von Ballmoos M, Likosky D, Rezaee M, Lobdell K, Alam S, Parker DM, Owens S, Thiessen-Philbrook H, MacKenzie T, Brown J. Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery. BMC Nephrol. 2018;19(1)

Stabler ME, Rezaee ME, Parker DM, MacKenzie TA, Bohm AR, DiScipio AW, Malenka DJ, Brown JR. sST2 as a Novel Biomarker for the Prediction of In-hospital Mortality after Coronary Artery Bypass Grafting. Biomarkers. 2019 May;24(3): 268-276.

Caracciolo C, Parker DM, Marshall E, Brown J. Excess readmissions vs excess penalties: maximum readmission penalties as a function of socioeconomics and geography. J Hosp Med. 2017 Aug;12(8):610-617.

Parker DM, Schang L, Wasserman JR, Viles WD, Bevan G, Goodman DC. Variation in utilization and need for tympanostomy tubes across England and New England. J Pediatr. 2016 Dec;179:178-184.

Corwin GS, Parker DM, Brown JR. Site of treatment for non-urgent conditions by Medicare beneficiaries: Is there a role for urgent care clinics? Am J Med. 2016 Sep;129(9):966-73.

Stroud AM, Parker DM, Croitoru DP. Timing of bariatric surgery for severely obese adolescents: a Markov decision-analysis. J Pediatr Surg. 2016 May;51(5):853-8.

Ralston S, Comick A, Nichols E, Parker DM, Lanter P. Effectiveness of Quality Improvement in Hospitalization for Bronchiolitis: A Systematic Review. Pediatrics. 2014 Sep;134(3):571-71.  

Goodman D, Morden N, Ralston S, Chang CH, Parker DM, Weinstein S. The Dartmouth Atlas of Children’s Health Care in Northern New England. A Report of the Dartmouth Atlas Project. 2013.

James P, Arcaya MC, Parker DM, Tucker-Seeley RD, Subramanian SV. Do minority and poor neighborhoods have higher access to fast-food restaurants in the United States? Health Place. 2014 Sep;29:10-7.